Replies to post #36359 on Humanigen Inc (HGENQ)

[cowtown jay]

At least, the fatigue will only be for this drug and the Covid indication. Approvals for lenz and ifab will come more quickly for CAR-T, GvHD, and CMML.

But getting authorized for Covid will take our microcap biotech to the blockbuster revenue level in and of itself.

And I agree that it was very reassuring that TLD is still targeted for Q2 release.